Bicycle Therapeutics (BCYC) Change in Account Payables (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Change in Account Payables data on file, last reported at -$59000.0 in Q2 2026.

• Quarterly Change in Account Payables fell 100.97% year-over-year to -$59000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$11.8 million (down 212.53% YoY) and the FY2025 annual result came in at -$6.9 million, down 322.0% from the prior year.
• Change in Account Payables advanced to -$59000.0 in Q2 2026, from -$3.8 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $10.7 million in Q4 2024 to a low of -$5.9 million in Q1 2024.
• A 5-year average of $160555.6 and a median of -$343000.0 in 2022 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2023 — Change in Account Payables plunged 684.71% — and 2025, when it soared 1515.08%.
• Tracing BCYC's Change in Account Payables over 5 years: stood at -$2.4 million in 2022, then jumped by 275.82% to $4.2 million in 2023, then surged by 156.49% to $10.7 million in 2024, then plunged by 126.96% to -$2.9 million in 2025, then jumped by 97.95% to -$59000.0 in 2026.
• The last three Change in Account Payables figures came in at -$59000.0 (Q2 2026), -$3.8 million (Q1 2026), and -$2.9 million (Q4 2025), per Business Quant data.